Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Lantheus Holdings (NQ: LNTH )

69.48 -0.05 (-0.07%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 29, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,263,530
Open 70.31
Bid (Size) 65.42 (1)
Ask (Size) 69.60 (2)
Prev. Close 69.53
Today's Range 68.44 - 70.44
52wk Range 47.46 - 99.32
Shares Outstanding 67,604,097
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Benzinga's Top Ratings Upgrades, Downgrades For September 29, 2023
Via Benzinga
While growth is established for NASDAQ:LNTH, the stock's valuation remains reasonable.
In the world of growth stocks, NASDAQ:LNTH shines as a value proposition. 
Via Chartmill

Performance

YTD
+37.12%
+37.12%
1 Month
+3.24%
+3.24%
3 Month
-17.06%
-17.06%
6 Month
-15.69%
-15.69%
1 Year
-6.76%
-6.76%

More News

Read More
Looking for growth without the hefty price tag? Consider NASDAQ:LNTH.
Via Chartmill
Analyst Ratings for Lantheus Holdings
Via Benzinga
Lantheus Holdings's Return On Capital Employed Overview
Via Benzinga
3 Stealth AI Stocks That Everyone Is Overlooking
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
3 AI Stocks That Should Be on Every Investor’s Radar This Fall
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
Lantheus Announces Top Rated Oral Presentation Featuring PYLARIFY AI™ at the 2023 European Association of Nuclear Medicine (EANM) Annual Meeting
From Lantheus Holdings, Inc.
Via GlobeNewswire
Lantheus to Present at the Wells Fargo Healthcare Conference
From Lantheus Holdings, Inc.
Via GlobeNewswire
Lantheus Announces Agreement to Sell RELISTOR® Royalties to HealthCare Royalty
From Lantheus Holdings, Inc.
Via GlobeNewswire
Lantheus Reports Second Quarter 2023 Financial Results
From Lantheus Holdings, Inc.
Via GlobeNewswire
Lantheus to Host Second Quarter 2023 Earnings Conference Call and Webcast on August 3, 2023, at 8:00 a.m. Eastern Time
From Lantheus Holdings, Inc.
Via GlobeNewswire
Neogen Stock Shows Market Leadership With Jump To 86 RS Rating
Via Investor's Business Daily
Lantheus Announces Presentations Featuring PYLARIFY AI™ at the 2023 Society for Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting
From Lantheus Holdings, Inc.
Via GlobeNewswire
2 Medical Imaging Stocks That Are Better Buys Than Nano-X
Via The Motley Fool
Lantheus to Present at the Jefferies Healthcare Conference
From Lantheus Holdings, Inc.
Via GlobeNewswire
Lantheus Announces Payment to Contingent Value Rights (CVR) Holders of $99.7 million or $1.15 per CVR
From Lantheus Holdings, Inc.
Via GlobeNewswire
7 Stocks That Wall Street Analysts Are Loving in May
Via InvestorPlace
Zillow, Shopify, Datadog And Other Big Stocks Moving Higher On Thursday
Via Benzinga
Market Rally Finishes Strong; Regional Banks, Fed Rate Hike, Jobs Report, Apple In Focus: Weekly Review
Via Investor's Business Daily
Why Shares of Lantheus Holdings Are Up Thursday
Via The Motley Fool
Why Synaptics Shares Are Trading Lower By 17%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Lantheus Reports First Quarter 2023 Financial Results
From Lantheus Holdings, Inc.
Via GlobeNewswire
Lantheus and POINT Biopharma Announce FDA Grants Fast Track Designation for ¹⁷⁷Lu-PNT2002 for the Treatment of Metastatic Castration Resistant Prostate Cancer
From Lantheus Holdings, Inc.; POINT Biopharma Global Inc.
Via GlobeNewswire
Lantheus to Host First Quarter 2023 Earnings Conference Call and Webcast on May 4, 2023, at 8:00 a.m. Eastern Time
From Lantheus Holdings, Inc.
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.